Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose cannabinoid extract for Alzheimer's disease
RBR-4cs7kjzPhase 2Completed
- Sponsor
- Federal University of Latin American Integration
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of cannabis extract in Alzheimer's disease (AD), sponsored by Federal University of Latin American Integration. Primary endpoint: Cognitive symptoms. Started Oct 2020; status: completed.
02
Drugs
cannabis extract
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on RBR-4cs7kjz.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4cs7kjz.